======= TBC1D22B =======
== Gene Information ==
* **Official Symbol**: TBC1D22B
* **Official Name**: TBC1 domain family member 22B
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=55633|55633]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9NU19|Q9NU19]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=TBC1D22B&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20TBC1D22B|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/616880|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: N/A
|TBC|
|14-3-3 protein binding|
|regulation of cilium assembly|
|cell|
|activation of GTPase activity|
|Rab GTPase binding|
|regulation of plasma membrane bounded cell projection assembly|
|regulation of cell projection assembly|
|regulation of organelle assembly|
|GTPase activator activity|
|positive regulation of GTPase activity|
|regulation of GTPase activity|
|regulation of plasma membrane bounded cell projection organization|
|regulation of cell projection organization|
|positive regulation of hydrolase activity|
|regulation of cellular component biogenesis|
|intracellular protein transport|
|regulation of hydrolase activity|
|regulation of organelle organization|
|positive regulation of catalytic activity|
|protein transport|
|intracellular transport|
|peptide transport|
|amide transport|
|cellular protein localization|
|cellular macromolecule localization|
|establishment of protein localization|
|positive regulation of molecular function|
|establishment of localization in cell|
|nitrogen compound transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp68|Clomiphene 4.4μM R02 exp68]]|-4.08|
|[[:results:exp434|Vemurafenib 6.6μM R08 exp434]]|-3.37|
|[[:results:exp454|Bafilomycin-A1 0.009μM R08 exp454]]|-3.12|
|[[:results:exp507|Monensin 0.3μM R08 exp507]]|-2.06|
|[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-1.83|
|[[:results:exp169|BH1 1μM R04 exp169]]|-1.72|
|[[:results:exp447|Amiloride 100μM R08 exp447]]|1.75|
^Gene^Correlation^
|[[:human genes:c:cog5|COG5]]|0.436|
|[[:human genes:g:gpr107|GPR107]]|0.421|
|[[:human genes:a:apba3|APBA3]]|0.42|
|[[:human genes:s:slc39a9|SLC39A9]]|0.412|
|[[:human genes:t:tbc1d23|TBC1D23]]|0.406|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 8613
* **Expression level (log2 read counts)**: 3.95
{{:chemogenomics:nalm6 dist.png?nolink |}}